Healthcare & Life Sciences
OWL Metabolomics
Spain
alive
About
OWL Metabolomics develops a metabolomics-based diagnostic platform and offers a non-invasive laboratory-developed test (LDT) for diagnosing nonalcoholic steatohepatitis (NASH).
Explore OWL Metabolomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.